000			01837 a2200493 4500
005			20250514185605.0
264		0	_c20040528
008			200405s 0 0 eng d
022			_a1569-9048
024	7		_a10.1016/j.resp.2003.10.007 _2doi
040			_aNLM _beng _cNLM
100	1		_aLalley, Peter M
245	0	0	_aDopamine1 receptor agonists reverse opioid respiratory network depression, increase CO2 reactivity. _h[electronic resource]
260			_bRespiratory physiology & neurobiology _cFeb 2004
300			_a247-62 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAction Potentials _xdrug effects
650	0	4	_aAnalgesics, Opioid
650	0	4	_aAnalysis of Variance
650	0	4	_aAnimals
650	0	4	_aApnea _xprevention & control
650	0	4	_aCarbon Dioxide _xpharmacology
650	0	4	_aCats
650	0	4	_aDecerebrate State
650	0	4	_aDopamine Agonists _xtherapeutic use
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Routes
650	0	4	_aDrug Interactions
650	0	4	_aElectric Stimulation
650	0	4	_aEnkephalin, Ala(2)-MePhe(4)-Gly(5)- _xpharmacology
650	0	4	_aFentanyl
650	0	4	_aIontophoresis _xmethods
650	0	4	_aMale
650	0	4	_aMedulla Oblongata _xcytology
650	0	4	_aNeurons _xdrug effects
650	0	4	_aPhrenic Nerve _xdrug effects
650	0	4	_aReaction Time
650	0	4	_aReceptors, Dopamine D1 _xagonists
650	0	4	_aRespiratory Insufficiency _xchemically induced
650	0	4	_aSensory Thresholds _xdrug effects
650	0	4	_aVagus Nerve _xdrug effects
773	0		_tRespiratory physiology & neurobiology _gvol. 139 _gno. 3 _gp. 247-62
856	4	0	_uhttps://doi.org/10.1016/j.resp.2003.10.007 _zAvailable from publisher's website
999			_c14833231 _d14833231